The comparison of hydroquinone and Melfade in the treatment of melasma
Phase 2
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT138809212840N1
- Lead Sponsor
- Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 62
Inclusion Criteria
woman with physician diagnosed melasma.
Exclusion criteria: history of the consumption of steroid, Melfade and hydroqinone drugs in recent 30 days, pregnancy, lactation, present history of OCP drug consumption.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Faint-colored of scar. Timepoint: 12 weeks. Method of measurement: observation.
- Secondary Outcome Measures
Name Time Method